Exercise of Options

RNS Number : 0697U
Quartix Holdings PLC
26 March 2019
 

Quartix Holdings plc

("Quartix" or the "Company")

 

Exercise of Options

 

Quartix Holdings plc, a leading supplier of vehicle telematics services to the fleet and insurance sectors, announces that it has issued 91,760 new ordinary shares in the Company (the "New Ordinary Shares") following the exercise of 11,760 options to subscribe for new ordinary shares in the Company at a price of 1 pence per new ordinary share and the exercise of a further 80,000 options to subscribe for new ordinary shares in the Company at a price of 44 pence per new ordinary share.

 

Application has been made for the New Ordinary Shares, which rank pari passu with the Company's existing issued ordinary shares, to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 1 April 2019. Following Admission the Company will have 47,938,320 ordinary shares in issue. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.  

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

For further information, please contact:

Quartix (www.quartix.net)

Andy Walters, Chief Executive Officer

Daniel Mandis, Chief Financial Officer

01686 806 663

finnCap (Nominated Adviser and Broker)

Matt Goode /Scott Mathieson (Corporate Finance)

Alice Lane (Corporate Broking)

020 7220 0500

 

Cantor Fitzgerald (Join Broker)

Phil Davies & Richard Salmon (Corporate Finance)

Caspar Shand-Kydd & Arthur Gordon  (Sales)

020 7894 7000

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEJFMITMBITBFL
UK 100

Latest directors dealings